Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer

Emerging data demonstrate homologous recombination (HR) defects in castration-resistant prostate cancers, rendering these tumours sensitive to PARP inhibition. Here we demonstrate a direct requirement for the androgen receptor (AR) to maintain HR gene expression and HR activity in prostate cancer. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Asim, Mohammad, Tarish, Firas, Zecchini, Heather I., Sanjiv, Kumar, Gelali, Eleni, Massie, Charles E., Baridi, Ajoeb, Warren, Anne Y., Zhao, Wanfeng, Ogris, Christoph, McDuffus, Leigh-Anne, Mascalchi, Patrice, Shaw, Greg, Dev, Harveer, Wadhwa, Karan, Wijnhoven, Paul, Forment, Josep V., Lyons, Scott R., Lynch, Andy G., O’Neill, Cormac, Zecchini, Vincent R., Rennie, Paul S., Baniahmad, Aria, Tavaré, Simon, Mills, Ian G., Galanty, Yaron, Crosetto, Nicola, Schultz, Niklas, Neal, David, Helleday, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575038/
https://www.ncbi.nlm.nih.gov/pubmed/28851861
http://dx.doi.org/10.1038/s41467-017-00393-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575038/
https://www.ncbi.nlm.nih.gov/pubmed/28851861
http://dx.doi.org/10.1038/s41467-017-00393-y

Ejemplares similares